These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 27189838)

  • 1. "Weariness" and "unpleasantness" reduce adherence to branched-chain amino acid granules among Japanese patients with liver cirrhosis: results of a single-center cross-sectional survey.
    Eguchi Y; Furukawa N; Furukawa T; Egashira Y; Hotokezaka H; Oeda S; Iwane S; Anzai K
    Hepatol Res; 2017 Mar; 47(3):E169-E177. PubMed ID: 27189838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of branched-chain amino acid granules on serum albumin level and prognosis are dependent on treatment adherence in patients with liver cirrhosis.
    Takaguchi K; Moriwaki H; Doyama H; Iida M; Yagura M; Shimada N; Kang M; Yamada H; Kumada H
    Hepatol Res; 2013 May; 43(5):459-66. PubMed ID: 23046471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The efficacy of nocturnal administration of branched-chain amino acid granules to improve quality of life in patients with cirrhosis.
    Hidaka H; Nakazawa T; Kutsukake S; Yamazaki Y; Aoki I; Nakano S; Asaba N; Minamino T; Takada J; Tanaka Y; Okuwaki Y; Watanabe M; Shibuya A; Koizumi W
    J Gastroenterol; 2013 Feb; 48(2):269-76. PubMed ID: 22825550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Late evening snacks with branched-chain amino acids improve the Fischer ratio with patients liver cirrhosis at fasting in the next morning.
    Maki H; Yamanaka-Okumura H; Katayama T; Ozawa Y; Hosoda A; Kurata N; Amemiya F
    Clin Nutr ESPEN; 2019 Apr; 30():138-144. PubMed ID: 30904214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of oral branched-chain amino acid granules on event-free survival in patients with liver cirrhosis.
    Muto Y; Sato S; Watanabe A; Moriwaki H; Suzuki K; Kato A; Kato M; Nakamura T; Higuchi K; Nishiguchi S; Kumada H;
    Clin Gastroenterol Hepatol; 2005 Jul; 3(7):705-13. PubMed ID: 16206505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral branched-chain amino acid granules reduce the incidence of hepatocellular carcinoma and improve event-free survival in patients with liver cirrhosis.
    Hayaishi S; Chung H; Kudo M; Ishikawa E; Takita M; Ueda T; Kitai S; Inoue T; Yada N; Hagiwara S; Minami Y; Ueshima K
    Dig Dis; 2011; 29(3):326-32. PubMed ID: 21829025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of Branched-Chain Amino Acid-Enriched Nutrient on liver Cirrhosis with Hepatocellular Carcinoma Undergoing Transcatheter Arterial Chemoembolization in Barcelona Clinic Liver Cancer Stage B: A Prospective Study.
    Shiozawa S; Usui T; Kuhara K; Tsuchiya A; Miyauchi T; Kono T; Asaka S; Yamaguchi K; Yokomizo H; Shimakawa T; Yoshimatsu K; Katsube T; Naritaka Y
    J Nippon Med Sch; 2016; 83(6):248-256. PubMed ID: 28133005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of the branched-chain amino acid to tyrosine ratio and branched-chain amino acid granule therapy in patients with hepatocellular carcinoma: A propensity score analysis.
    Tada T; Kumada T; Toyoda H; Kiriyama S; Tanikawa M; Hisanaga Y; Kanamori A; Kitabatake S; Yama T
    J Gastroenterol Hepatol; 2015 Sep; 30(9):1412-9. PubMed ID: 25799910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of long-term oral supplementation with branched-chain amino acid granules on the prognosis of liver cirrhosis.
    Yoshida T; Muto Y; Moriwaki H; Yamato M
    Gastroenterol Jpn; 1989 Dec; 24(6):692-8. PubMed ID: 2606303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral supplementation with branched-chain amino acid granules prevents hepatocarcinogenesis in patients with hepatitis C-related cirrhosis: A propensity score analysis.
    Tada T; Kumada T; Toyoda H; Kiriyama S; Tanikawa M; Hisanaga Y; Kanamori A; Kitabatake S; Niinomi T; Ito T; Hasegawa R; Ando Y; Yamamoto K; Tanaka T
    Hepatol Res; 2014 Mar; 44(3):288-95. PubMed ID: 23607436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of oral supplementation with branched-chain amino acid granules in the early stage of cirrhosis.
    Nishiguchi S; Habu D
    Hepatol Res; 2004 Dec; 30S():36-41. PubMed ID: 15607137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Importance of branched-chain amino acids in patients with liver cirrhosis and advanced hepatocellular carcinoma receiving hepatic arterial infusion chemotherapy.
    Kanekawa T; Nagai H; Kanayama M; Sumino Y
    Cancer Chemother Pharmacol; 2014 Nov; 74(5):899-909. PubMed ID: 25138286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the effect of BCAA granules on between decompensated and compensated cirrhosis.
    Habu D; Nishiguchi S; Nakatani S; Lee C; Enomoto M; Tamori A; Takeda T; Ohfuji S; Fukushima W; Tanaka T; Kawamura E; Shiomi S
    Hepatogastroenterology; 2009; 56(96):1719-23. PubMed ID: 20214224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppressive effect of oral administration of branched-chain amino acid granules on oxidative stress and inflammation in HCV-positive patients with liver cirrhosis.
    Ohno T; Tanaka Y; Sugauchi F; Orito E; Hasegawa I; Nukaya H; Kato A; Matunaga S; Endo M; Tanaka Y; Sakakibara K; Mizokami M
    Hepatol Res; 2008 Jul; 38(7):683-8. PubMed ID: 18328070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Supplementation of branched-chain amino acids maintains the serum albumin level in the course of hepatocellular carcinoma recurrence.
    Kakazu E; Kondo Y; Kogure T; Ninomiya M; Kimura O; Iwata T; Morosawa T; Iwasaki T; Shimosegawa T
    Tohoku J Exp Med; 2013 Aug; 230(4):191-6. PubMed ID: 23892757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of branched-chain amino acid supplementation after radiofrequency ablation for hepatocellular carcinoma: A randomized trial.
    Nojiri S; Fujiwara K; Shinkai N; Iio E; Joh T
    Nutrition; 2017 Jan; 33():20-27. PubMed ID: 27908546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heating improves poor compliance with branched chain amino acid-rich supplementation in patients with liver cirrhosis: A before-after pilot study.
    Itou M; Kawaguchi T; Taniguchi E; Shiraishi S; Ibi R; Mutou M; Okada T; Uchida Y; Otsuka M; Oriishi T; Tanaka S; Takakura M; Mitsuyama K; Tsuruta O; Sata M
    Mol Med Rep; 2009; 2(6):983-7. PubMed ID: 21475931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of oral supplementation with branched-chain amino acid granules on serum albumin level in the early stage of cirrhosis: a randomized pilot trial.
    Habu D; Nishiguchi S; Nakatani S; Kawamura E; Lee C; Enomoto M; Tamori A; Takeda T; Tanaka T; Shiomi S
    Hepatol Res; 2003 Mar; 25(3):312-318. PubMed ID: 12697253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is administrating branched-chain amino acid-enriched nutrition achieved symptom-free in malnourished cirrhotic patients?
    Tsuda Y; Fukui H; Sujishi T; Ohama H; Tsuchimoto Y; Asai A; Fukunisi S; Higuchi K
    J Clin Biochem Nutr; 2014 Jan; 54(1):51-4. PubMed ID: 24426191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nocturnal branched-chain amino acid administration improves protein metabolism in patients with liver cirrhosis: comparison with daytime administration.
    Fukushima H; Miwa Y; Ida E; Kuriyama S; Toda K; Shimomura Y; Sugiyama A; Sugihara J; Tomita E; Moriwaki H
    JPEN J Parenter Enteral Nutr; 2003; 27(5):315-22. PubMed ID: 12971730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.